You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb1516292 |
---|---|
Category | Proteins |
Description | Recombinant human VEGFR2 protein, C-His-Avi (HEK293) |
Tag | C-His-Avi |
Concentration | >0.5 mg/ml |
Form/Appearance | Lyophilized |
Purity | > 95% as determined by Tris-Bis PAGE; > 95% as determined by SEC-HPLC |
MW | Due to glycosylation, the protein migrates to 115-140 kDa based on Tris-Bis PAGE result. |
Target | Vascular endothelial growth factor receptor 2 |
Protein Sequence | 20-764/1356 |
Expression System | HEK293 cell |
Biological Activity | Not tested |
Endotoxins | < 1.0 EU/μg as determined by LAL |
Storage | Stored at -70°C or -20°C. Avoid repeated freeze/thaw cycles. |
Buffer/Preservatives | Lyophilized from 0.22um filtered solution in PBS (pH7.4) with 5mM DTT. Normally 5% trehalose is added as protectant before Lyophilization. |
Alternative names | Vascular endothelial growth factor receptor 2; KDR Read more... |
Note | For research use only |
Application notes | Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. |
Expiration Date | 6 months from date of receipt. |
Immobilized Human VEGFR2, His Tag at 0.5 ug/ml (100 ul/Well). Dose response curve for Anti-VEGFR2 Ab. with the EC50 of 36.9 ng/ml determined by ELISA.
Recombinant Human KDR /VEGFR2 Protein on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
The purity of Recombinant Human KDR /VEGFR2 Protein is greater than 95% as determined by SEC-HPLC.
98.00% | |
86.2 kDa (predicted). Due to glycosylation, the protein migrates to 115-140 kDa based on Tris-Bis PAGE result. |